Pulmatrix secures FDA approval for Pulmazole phase 2 clinical study
Pulmazole phase 2 clinical study : Pulmatrix said that the US Food and Drug Administration (FDA) has authorized the Massachusetts-based
Continue reading
Tag: Pulmazole
Latest Pharma Industry News
-
Dr Reddy’s Laboratories to acquire generic injectable products in the US
-
Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men
-
Novartis to acquire IFM Tre with eye on immunomodulatory drugs
-
Ethicon wraps up $3.4bn acquisition of robotic medical company Auris Health
-
US CDMO Brammer Bio to be acquired by Thermo Fisher
-
Italian CDMO Olon wraps up acquisition of Mahad API plant in India
-
Lilly teams up with ImmuNext for developing drugs for autoimmune diseases
-
Arch Oncology raises $50m to advance anti-CD47 antibody therapies
-
Merck to invest €150m to expand Aubonne biotech manufacturing site
-
RepHresh brand rolls out RepHresh Cooling Relief Vaginal Anti-Itch Spray
Business News Today
- Victoria’s Secret launches summer fragrance collection Bombshell Paradise
- CBA to roll out low alcohol, low-calorie Pacer Low Proof Seltzer range
- Ameriprise Financial to sell Ameriprise Auto & Home to American Family
- Duke Energy inaugurates 1.64GW Citrus County power plant in Florida
- Torani rolls out new Puremade range of syrups and sauces
- FMG, Formosa approve Iron Bridge Magnetite Project stage 2 development
- Campbell Soup to sell Bolthouse Farms to Butterfly Equity for $510m
- Center Rock acquires Merit Distribution from Centre Lane Partners
- pladis launches chocolate-covered pretzel brand Flipz Mix in US
- Dacor opens new kitchen appliance showroom in Chicago
